Citadel Advisors’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$50.4M Sell
598,902
-168,079
-22% -$12.2M 0.01% 1352
2025
Q4
$57.9M Sell
766,981
-402,263
-34% -$25.3M 0.01% 1284
2025
Q3
$46.5M Buy
1,169,244
+673,585
+136% +$25.7M 0.01% 1468
2025
Q2
$21.5M Buy
495,659
+429,477
+649% +$16.3M ﹤0.01% 2052
2025
Q1
$2.47M Sell
66,182
-6,542
-9% -$253K ﹤0.01% 5127
2024
Q4
$3.29M Buy
+72,724
New +$3.71M ﹤0.01% 4682
2024
Q3
Sell
-116,318
Closed -$5.57M 14186
2024
Q2
$4.58M Buy
+116,318
New +$5.65M ﹤0.01% 3890
2023
Q4
Sell
-243,126
Closed -$5.18M 14223
2023
Q3
$5.18M Buy
+243,126
New +$5.36M ﹤0.01% 3590

Other funds holding APGE